TLR9-induced miR-155 and Ets-1 decrease expression of CD1d on B cells in SLE

Correcting the expression of miRNA-155 represses PP2Ac and enhances the release of IL-2 in PBMCs of juvenile SLE patients

(2014) Y A Lashine et al.   LUPUS

Viruses as potential pathogenic agents in systemic lupus erythematosus

(2014) P Nelson et al.   LUPUS

Activation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus

(2014) H Fan et al.   Cell Death & Disease

A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW/F1 mice

(2013) Fu-Gang Zhu et al.   AUTOIMMUNITY

Innate immune control of EBV-infected B cells by invariant natural killer T cells

(2013) B. K. Chung et al.   BLOOD

Review of Ets1 structure, function, and roles in immunity

(2013) Lee Ann Garrett-Sinha   CELLULAR AND MOLECULAR LIFE SCIENCES

Autoantibody Induction by DNA-Containing Immune Complexes Requires HMGB1 with the TLR2/MicroRNA-155 Pathway

(2013) Z. Wen et al.   JOURNAL OF IMMUNOLOGY

Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Faslpr mouse

(2013) T.-H. Thai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

17β-Estradiol enhances response of mice spleen B cells elicited by TLR9 agonist

(2012) Yixin Xu et al.   CELLULAR IMMUNOLOGY

Lipid-Antigen Presentation by CD1d+ B Cells Is Essential for the Maintenance of Invariant Natural Killer T Cells

(2012) Anneleen Bosma et al.   IMMUNITY

Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing

(2012) Leon N. Schulte et al.   NUCLEIC ACIDS RESEARCH

MicroRNA-155 as a therapeutic target for inflammatory diseases

(2012) Naghmana Kanwal et al.   RHEUMATOLOGY INTERNATIONAL

Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus

(2012) Honglei Wang et al.   Translational Research

Replicated associations of TNFAIP3, TNIP1 and ETS1 with systemic lupus erythematosus in a southwestern Chinese population

(2012) Hua Zhong et al.   ARTHRITIS RESEARCH & THERAPY

Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression

(2011) E. Stagakis et al.   ANNALS OF THE RHEUMATIC DISEASES

Invariant NKT Cells Inhibit Autoreactive B Cells in a Contact- and CD1d-Dependent Manner

(2011) J.-Q. Yang et al.   JOURNAL OF IMMUNOLOGY

B-cell targeted therapies in human autoimmune diseases: an updated perspective

(2010) Michael J. Townsend et al.   IMMUNOLOGICAL REVIEWS

Inducible microRNA-155 Feedback Promotes Type I IFN Signaling in Antiviral Innate Immunity by Targeting Suppressor of Cytokine Signaling 1

(2010) P. Wang et al.   JOURNAL OF IMMUNOLOGY

B cells as therapeutic targets in SLE

(2010) Iñaki Sanz et al.   Nature Reviews Rheumatology

Identification of Unique MicroRNA Signature Associated with Lupus Nephritis

(2010) Jeannie L. Te et al.   PLoS One

Identification of a Common Lupus Disease-Associated microRNA Expression Pattern in Three Different Murine Models of Lupus

(2010) Rujuan Dai et al.   PLoS One

Aberrant Epstein–Barr viral infection in systemic lupus erythematosus

(2009) Brian D. Poole et al.   AUTOIMMUNITY REVIEWS

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Emerging roles of TLR7 and TLR9 in murine SLE

(2009) Marie-Laure Santiago-Raber et al.   JOURNAL OF AUTOIMMUNITY

Inositol phosphatase SHIP1 is a primary target of miR-155

(2009) R. M. O'Connell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Systemic Lupus Erythematosus

(2008) Anisur Rahman et al.   NEW ENGLAND JOURNAL OF MEDICINE